The heart of the matter

Your laboratory demands accurate, fast results in cardiac care. We offer comprehensive cardiac solutions that are a natural fit for laboratories. Our assays and analyzers provide accurate, reliable results with rapid turnaround time, aiding clinicians in providing better patient care. 

For in vitro diagnostic use.

Challenges

Cardiovascular disease (cvd) is a broad term for a range of diseases affecting the heart and blood vessels.

Most sudden cardiac deaths, approximately 70–90%, occur outside a hospital1 

Cardiovascular disease (cvd) is the #1 cause of death2

In 2021, there were 612 million cases of CVD globally3

31.7% projected deaths from cvd by 20304

A more accurate assessment tool for the identification on future cardiovascular risk

Leverage the power of Abbott's STAT High Sensitive Troponin-I to help more accurately identify in apparently healthy individuals who is at risk of a future cardiac event.

Redefining precision For heart attack

Gain confidence in results with excellent precision of our STAT High Sensitive Troponin-I assays.

Delivering choices for Heart failure testing

To aid in diagnosis and assessment of severity of heart failure, Abbott provides a choice of heart failure tests offering both BNP and NT-proBNP biomarkers.

Core Laboratory Menus and Systems

View and download the Core Laboratory menus to see the complete list of available assays and in development assays, categorized by instrument.

Some assays may not be available on all platforms or in all regions.



Cardiac
Alere NT-proBNP
BNP
CK-MB 
D-Dimer
Galectin-3
Homocysteine
Myoglobin
STAT CK-MB
STAT High Sensitive Troponin-I
STAT Myoglobin
Explore

Stay Connected

Subscribe to Abbott's Core Lab newsletter to stay updated on our latest innovations, product launches, publications and events. 

AlinIQ Indexor

Learn about the patient sample tracking system that gives labs increased visibility on transport conditions, automates accessioning and more.

Transformation System by Abbott

Unleash your lab’s potential with Abbott’s Transformation System. Engage stakeholders to unlock value and deliver better outcomes

References
  1. American Red Cross. CPR Facts & Statistics. Updated January 6, 2026. Accessed March 11, 2026.
  2. World Health Organization. Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(CVDs). Published July 31, 2025. Accessed March 11, 2026. 
  3. Tan SCW, Zheng BB, Tang ML, Chu H, Zhao YT, Weng C. Global Burden of Cardiovascular Diseases and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. QJM. 2025;118(6):411‑422. doi:10.1093/qjmed/hcaf022.
  4. Varounis C, Beshiri A. The future of cardiovascular disease prevention: a risk registry approach. Nature (Sponsor Feature). Abbott Laboratories; 2021. Accessed March 11, 2026.